Concordance between Research Sequencing and Clinical Pharmacogenetic Genotyping in the eMERGE-PGx Study

Overview of attention for article published in The Journal of Molecular Diagnostics, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 12,359 followers.

Concordance between Research Sequencing and Clinical Pharmacogenetic Genotyping in the eMERGE-PGx Study https://t.co/eGGZBKaOrm

Interesting, but I wonder what FDA and CLIA will think about this... https://t.co/WnY9HNQbXG

Sanger confirmation might not be necessary for clinical #PGx by #NGS https://t.co/rORRaQ2khr

Concordance between research sequencing & clinical pharmacogenetic genotyping <-- new from @eMERGENetwork_ PGx Study https://t.co/HCnbuEU0cj

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.